 |
Minimale Einzahlung $50 Exklusive Aktion |
Unser Ergebnis |
0% Kommission |
Are you looking to buy Regeneron Pharmaceuticals stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:REGN! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Regeneron Pharmaceuticals stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. The company’s products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema (DME); myopic choroidal neovascularization; and diabetic retinopathy in patients with DME, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis in adults, and asthma in adults and adolescents; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; and Kevzara solution for subcutaneous injection for treating rheumatoid arthritis in adults. In addition, the company offers Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer. Further, it is developing various product candidates for treating patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neuromuscular diseases, infectious diseases, and other diseases. The company has collaboration and license agreements with Sanofi; Bayer; Teva; Mitsubishi Tanabe Pharma; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Vyriad, Inc., as well as has an agreement with the U.S. Department of Health and Human Services. It has collaborations with Zai Lab Limited; Intellia Therapeutics, Inc.; and BioNTech. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Tarrytown, New York.
Durchschnittliches Volumen
1,06 Millionen Aktien
MARKTKAPPE
$53.04 billion
Börse
NASDAQ
Kaufen Sie diese Aktie!
|
NAME
|
TICKER
|
INDUSTRIE
|
SECTOR
|
VOLUME
|
KAUFEN SIE DIESE AKTIE JETZT
|
|---|---|---|---|---|---|
|
NASDAQ:REGN
|
Pharmazeutische Präparate
|
Medizinisch
|
27,819 shs
|
Below is a quick guide on how to buy NASDAQ:REGN stocks safe, fast and around the world in less than five minutes.
Schritt 1: Eröffnen Sie ein Konto bei eToro – eToro is the best broker to buy Regeneron Pharmaceuticals shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Schritt 2: Laden Sie Ihre ID hoch - Gemäß den KYC-Vorschriften wird eToro Sie bitten, eine Kopie Ihres Reisepasses oder Führerscheins hochzuladen.
Schritt 3: Geld einzahlen - Zahlen Sie etwas Geld auf Ihr neu eingerichtetes eToro Konto ein. Sie können zwischen Banküberweisung, E-Wallet, Debit-/Kreditkarte oder Paypal wählen.
Schritt 4: Buy Regeneron Pharmaceuticals – Search for “”NASDAQ:REGN”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Regeneron Pharmaceuticals stocks with 0% commission!.
1 | | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
25 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Regeneron Pharmaceuticals in the last twelve months. There are currently 6 hold ratings, 18 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should “buy” Regeneron Pharmaceuticals stock.
Wall Street analysts have given Regeneron Pharmaceuticals a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Regeneron Pharmaceuticals wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
2 |  | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
3 |  | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:REGN stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Regeneron Pharmaceuticals stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Regeneron Pharmaceuticals stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Da es sich bei eToro um eine regulierte Plattform handelt, müssen Sie das KYC-Verfahren abschließen. Dies ist gängige Praxis und dauert nur ein paar Minuten. Sie müssen einen Lichtbildausweis (Reisepass, Führerschein) und einen Adressnachweis (Stromrechnung, Kontoauszug) vorlegen.
Sobald Sie sich angemeldet und Ihr Konto verifiziert haben, müssen Sie Geld einzahlen. eToro akzeptiert Kredit-/Debitkarten, Banküberweisungen und auch E-Wallets. Was auch immer Sie bevorzugen, es wird etwas für Sie dabei sein.
Now that you’ve funded your eToro account, just type “NASDAQ:REGN stocks" in die Suchleiste am oberen Rand des Bildschirms ein und drücken Sie auf "Handeln".
All that’s left is to buy some NASDAQ:REGN stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:REGN is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Regeneron Pharmaceuticals stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Regeneron Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Tuesday, May 4th 2021.
View our earnings forecast for Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) released its quarterly earnings results on Thursday, February, 4th. The biopharmaceutical company reported $9.53 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $7.11 by $2.42. The biopharmaceutical company had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.40 billion. Regeneron Pharmaceuticals had a trailing twelve-month return on equity of 28.97% and a net margin of 38.28%. The firm’s revenue for the quarter was up 11.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $7.50 EPS.
View Regeneron Pharmaceuticals’ earnings history.
Regeneron Pharmaceuticals’ stock was trading at $464.70 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, REGN stock has increased by 8.1% and is now trading at $502.18.
Regeneron Pharmaceuticals declared that its Board of Directors has approved a share repurchase plan on Tuesday, November 5th 2019, which authorizes the company to buyback $1,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to buy up to 2.9% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s board believes its shares are undervalued.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:REGN stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Mehr als 95% der Kundengelder werden offline, in kalten Lagern, aufbewahrt, was für jeden Broker, der Ihr Vermögen verwaltet, entscheidend ist. Unabhängig davon, wie sicher eine Plattform sein soll, empfehlen wir die Verwendung von 2FA, um eine zusätzliche Sicherheitsebene für Ihr Konto zu schaffen.
eToro bietet Nutzern eine Reihe von Funktionen, um so schnell wie möglich mit dem Investieren zu beginnen. Es gibt eine relativ einzigartige Funktion namens Copy Trading, mit der Sie ein passives Einkommen erzielen können, indem Sie erfahrene Händler spiegeln. So können Sie schnell Gewinne erzielen und erhalten ein besseres Verständnis für die Strategien, die von Profis verwendet werden. Außerdem können Sie bei eToro in verwaltete Portfolios investieren. Ein verwaltetes Portfolio besteht aus einer Vielzahl ähnlicher Vermögenswerte, die in Gruppen zusammengefasst sind. Wenn Sie bereits über Handelserfahrung verfügen, können Sie auch in andere Märkte als Aktien investieren, da eToro den Handel mit ETFs, Rohstoffen, Kryptowährungen und Indizes ermöglicht. Wenn Sie bereits außerhalb des Aktienmarktes investieren, kann dies sehr nützlich sein, da Sie so alle Ihre Investitionen an einem einzigen Ort verwalten können.
25 Wall Street analysts have issued 12 month target prices for Regeneron Pharmaceuticals’ stock. Their forecasts range from $429.00 to $800.00. On average, they expect Regeneron Pharmaceuticals’ stock price to reach $617.79 in the next year. This suggests a possible upside of 23.0% from the stock’s current price.
View analysts’ price targets for Regeneron Pharmaceuticals or view top-rated stocks among Wall Street analysts.
Regeneron Pharmaceuticals’ management team includes the following people:
Dr. Leonard S. Schleifer, Co-Founder, Pres, CEO & Exec. Director (Age 68, Pay $4.77M)
Dr. George D. Yancopoulos, Co-Founder, Pres & Chief Scientific Officer & Director (Age 61, Pay $3.98M)
Mr. Robert E. Landry Jr., Exec. VP of Fin. & CFO (Age 57, Pay $1.56M)
Dr. Andrew J. Murphy, Exec. VP of Research (Age 63, Pay $1.29M)
Mr. Daniel P. Van Plew, Exec. VP and GM of Industrial Operations & Product Supply (Age 48, Pay $1.46M)
Ms. Patrice Gilooly, Sr. VP of Quality Assurance & Operations
Mr. Christopher R. Fenimore, Sr. VP, Head of Accounting & Controller (Age 50)
Mr. Gerald Underwood, Sr. VP of Technical Operations
Mr. Bob McCowan, Sr. VP of IT & Chief Information Officer
Justin Holko, VP of Investor Relations
CFDs sind komplexe Instrumente und bergen aufgrund der Hebelwirkung ein hohes Risiko, schnell Geld zu verlieren. 68% der Konten von Kleinanlegern verlieren Geld beim Handel mit CFDs bei diesem Anbieter. Sie sollten sich überlegen, ob Sie verstehen, wie CFDs funktionieren und ob Sie das hohe Risiko, Ihr Geld zu verlieren, eingehen können.
423 employees have rated Regeneron Pharmaceuticals CEO Leonard S. Schleifer on Glassdoor.com. Leonard S. Schleifer has an approval rating of 87% among Regeneron Pharmaceuticals’ employees.
Some companies that are related to Regeneron Pharmaceuticals include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Seagen (SGEN), Alexion Pharmaceuticals (ALXN), Exact Sciences (EXAS), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), Novavax (NVAX), BioMarin Pharmaceutical (BMRN), Repligen (RGEN), Neurocrine Biosciences (NBIX), Ionis Pharmaceuticals (IONS) and United Therapeutics (UTHR).
View all of REGN’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other Regeneron Pharmaceuticals investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Netflix (NFLX), Tesla (TSLA), Alibaba Group (BABA), Johnson & Johnson (JNJ), The Walt Disney (DIS), Micron Technology (MU), Advanced Micro Devices (AMD) and salesforce.com (CRM).
Regeneron Pharmaceuticals trades on the NASDAQ under the ticker symbol “REGN.”
1 | | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
Regeneron Pharmaceuticals’ stock is owned by many different institutional and retail investors. Top institutional shareholders include FMR LLC (10.76%), BlackRock Inc. (9.16%), California Public Employees Retirement System (0.78%), Swiss National Bank (0.56%), Sumitomo Mitsui Trust Holdings Inc. (0.42%) and Candriam Luxembourg S.C.A. (0.38%). Company insiders that own Regeneron Pharmaceuticals stock include Andrew J Murphy, Arthur F Ryan, Bonnie L Bassler, Christopher R Fenimore, George L Sing, Huda Y Zoghbi, Joseph J Larosa, Joseph L Goldstein, Leonard S Schleifer, Marion Mccourt, Michael S Brown, Neil Stahl, P Roy Vagelos, Plew Daniel P Van, Robert E Landry and Sanofi.
View institutional ownership trends for Regeneron Pharmaceuticals.
REGN stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, First Trust Advisors LP, FIL Ltd, BlackRock Inc., Robeco Institutional Asset Management B.V., Sumitomo Mitsui Trust Holdings Inc., Hexavest Inc., and Aperio Group LLC. Company insiders that have sold Regeneron Pharmaceuticals company stock in the last year include Andrew J Murphy, Arthur F Ryan, Bonnie L Bassler, Christopher R Fenimore, George L Sing, Huda Y Zoghbi, Joseph J Larosa, Joseph L Goldstein, Leonard S Schleifer, Marion Mccourt, Michael S Brown, Neil Stahl, P Roy Vagelos, Plew Daniel P Van, and Robert E Landry.
View insider buying and selling activity for Regeneron Pharmaceuticals or view top insider-selling stocks.
REGN stock was purchased by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Candriam Luxembourg S.C.A., NN Investment Partners Holdings N.V., Swiss National Bank, Bronte Capital Management Pty Ltd., Rhenman & Partners Asset Management AB, Hendershot Investments Inc., and Clark Capital Management Group Inc..
View insider buying and selling activity for Regeneron Pharmaceuticals or or view top insider-buying stocks.
Shares of REGN can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interaktive Makler Bewertung, eToro Überprüfung, DEGiro Rückblick, AvaTrade Bewertung, IG Markets Rückblick, IC Märkte Rückblick, CMC Markets Rückblick, Admiral Markets Rückblick und viele mehr. Lesen Sie eine der Bewertungen, um alles über den Broker zu erfahren, und beginnen Sie jetzt mit dem Kauf von Aktien.
One share of REGN stock can currently be purchased for approximately $502.18.
Regeneron Pharmaceuticals has a market capitalization of $53.59 billion and generates $7.86 billion in revenue each year. The biopharmaceutical company earns $2.12 billion in net income (profit) each year or $21.47 on an earnings per share basis.
Wir von Reportlab.org möchten sicherstellen, dass Sie alle wichtigen Informationen über Aktien kaufen. Wir bieten Ihnen die besten Leitfäden zum Thema Börse mit persönlichen Bewertungen, Hintergrundinformationen, Plattformbewertungen, Anleitungen und mehr. Möchten Sie weitere Informationen erhalten? Dann schauen Sie sich die OTC-Aktien, NASDAQ-Aktien, NYSE-Aktien, LON-Aktien, FRA-Aktien, ETR-Aktien, EPA-Bestände, TSX-Aktien oder Amex Aktien. Sie suchen nach detaillierteren Informationen wie 5g Vorräte, Biotech-Aktien, Goldvorräte und andere Informationen aus unserem Reportlab.
How can you buy Regeneron Pharmaceuticals stock on the internet?
You can easily buy Regeneron Pharmaceuticals stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Eine weitere Option ist die Nutzung eines regulierten Brokers wie IC-Märkte oder Interaktive Makler. You can an account with these brokers and start buying or trading NASDAQ:REGN stocks in a safe and complete environment to trade in.
Where to buy Regeneron Pharmaceuticals stock?
You will first want to find a licensed broker that supports NASDAQ:REGN stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:REGN stocks in a safe and complete environment.
Is NASDAQ:REGN stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:REGN stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Regeneron Pharmaceuticals stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:REGN is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Regeneron Pharmaceuticals stock.
How do you trade Regeneron Pharmaceuticals stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Regeneron Pharmaceuticals stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:REGN stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Regeneron Pharmaceuticals stock?
To sell your NASDAQ:REGN stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Regeneron Pharmaceuticals stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:REGN stock.
Stephen kennt sich gut mit Finanzprodukten aus und hat insbesondere eine große Leidenschaft für die Aktienmärkte und ihre Teilnehmer. Wir hoffen, dass die bereitgestellten Informationen Ihnen helfen werden. Ist Ihnen etwas nicht ganz klar? Bitte hinterlassen Sie Ihre Fragen oder Kommentare unten auf der Seite.
| Unser Ergebnis ★★★★★ | |
| Unser Ergebnis ★★★★★ | |
| Unser Ergebnis ★★★★★ |
Newsletter
Neueste Nachrichten
| |
Unser Ergebnis |
0% Kommission |
Alle EPA-Aktien Weitere Informationen EPA-Aktien Was ist die Pariser Börse (EPA)? Jetzt
Aktien & Krypto-Daten in Echtzeit
Benachrichtigungen, Tipps & Neuigkeiten
Beste Aktien & Krypto-Führer
Online Broker & Börse Bewertungen
Reportlab Finanzen ist eine rein informative Website und stellt in keinem Fall eine Anlageberatung dar. Alle Investitionen sind mit Risiken verbunden und Sie können Ihre gesamten Investitionen verlieren. Investieren Sie kein Geld, das Sie sich nicht leisten können, zu verlieren.
Reportlab Finanzen
38 Holburn Lane
Heckfield Green
IP21 0UB
Vereinigtes Königreich
Copyright © 2022 Reportlab.Finance | Alle Rechte vorbehalten.
